[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Point of Care Infectious Disease Testing Market Research Report 2023

December 2023 | 97 pages | ID: GA7807AF6633EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Infectious disease doctors test your blood or other body fluids to look for specific antibodies — cells produced by our immune system to fight harmful foreign substances. These tests can indicate what kind of infection is present. For bacterial infections, treatment usually involves antibiotics. Launch of mobile & self-testing devices has increased access to testing and monitoring systems to the remote places where the provision of timely medical care is a challenge.

According to QYResearch’s new survey, global Point of Care Infectious Disease Testing market is projected to reach US$ 4411.8 million in 2029, increasing from US$ 2635 million in 2022, with the CAGR of 7.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Point of Care Infectious Disease Testing market research.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Point of Care Infectious Disease Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
  • Alere
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • BD
  • Chembio Diagnostics
  • Trinity Biotech
  • Cardinal Health
  • Quest Diagnostics
  • Bio-Rad Labs
  • bioMйrieux
  • Sight Diagnostics
  • Gene POC
  • Trivitron Healthcare
  • OJ-Bio
  • Ortho-Clinical Diagnostics
Segment by Type
  • HIV POC
  • HBV POC
  • Pneumonia or Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV) POC
  • HPV POC
  • Influenza POC
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Home
  • Others
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
The Point of Care Infectious Disease Testing report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Point of Care Infectious Disease Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 HIV POC
  1.2.3 HBV POC
  1.2.4 Pneumonia or Streptococcus Associated Infections
  1.2.5 Respiratory Syncytial Virus (RSV) POC
  1.2.6 HPV POC
  1.2.7 Influenza POC
  1.2.8 Others
1.3 Market by Application
  1.3.1 Global Point of Care Infectious Disease Testing Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Home
  1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Point of Care Infectious Disease Testing Market Perspective (2018-2029)
2.2 Point of Care Infectious Disease Testing Growth Trends by Region
  2.2.1 Global Point of Care Infectious Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Point of Care Infectious Disease Testing Historic Market Size by Region (2018-2023)
  2.2.3 Point of Care Infectious Disease Testing Forecasted Market Size by Region (2024-2029)
2.3 Point of Care Infectious Disease Testing Market Dynamics
  2.3.1 Point of Care Infectious Disease Testing Industry Trends
  2.3.2 Point of Care Infectious Disease Testing Market Drivers
  2.3.3 Point of Care Infectious Disease Testing Market Challenges
  2.3.4 Point of Care Infectious Disease Testing Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Point of Care Infectious Disease Testing Players by Revenue
  3.1.1 Global Top Point of Care Infectious Disease Testing Players by Revenue (2018-2023)
  3.1.2 Global Point of Care Infectious Disease Testing Revenue Market Share by Players (2018-2023)
3.2 Global Point of Care Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care Infectious Disease Testing Revenue
3.4 Global Point of Care Infectious Disease Testing Market Concentration Ratio
  3.4.1 Global Point of Care Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Testing Revenue in 2022
3.5 Point of Care Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Point of Care Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Point of Care Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 POINT OF CARE INFECTIOUS DISEASE TESTING BREAKDOWN DATA BY TYPE

4.1 Global Point of Care Infectious Disease Testing Historic Market Size by Type (2018-2023)
4.2 Global Point of Care Infectious Disease Testing Forecasted Market Size by Type (2024-2029)

5 POINT OF CARE INFECTIOUS DISEASE TESTING BREAKDOWN DATA BY APPLICATION

5.1 Global Point of Care Infectious Disease Testing Historic Market Size by Application (2018-2023)
5.2 Global Point of Care Infectious Disease Testing Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Point of Care Infectious Disease Testing Market Size (2018-2029)
6.2 North America Point of Care Infectious Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Point of Care Infectious Disease Testing Market Size by Country (2018-2023)
6.4 North America Point of Care Infectious Disease Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Point of Care Infectious Disease Testing Market Size (2018-2029)
7.2 Europe Point of Care Infectious Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Point of Care Infectious Disease Testing Market Size by Country (2018-2023)
7.4 Europe Point of Care Infectious Disease Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Point of Care Infectious Disease Testing Market Size (2018-2029)
8.2 Asia-Pacific Point of Care Infectious Disease Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Point of Care Infectious Disease Testing Market Size (2018-2029)
9.2 Latin America Point of Care Infectious Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Point of Care Infectious Disease Testing Market Size by Country (2018-2023)
9.4 Latin America Point of Care Infectious Disease Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Point of Care Infectious Disease Testing Market Size (2018-2029)
10.2 Middle East & Africa Point of Care Infectious Disease Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Alere
  11.1.1 Alere Company Detail
  11.1.2 Alere Business Overview
  11.1.3 Alere Point of Care Infectious Disease Testing Introduction
  11.1.4 Alere Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.1.5 Alere Recent Development
11.2 Thermo Fisher Scientific
  11.2.1 Thermo Fisher Scientific Company Detail
  11.2.2 Thermo Fisher Scientific Business Overview
  11.2.3 Thermo Fisher Scientific Point of Care Infectious Disease Testing Introduction
  11.2.4 Thermo Fisher Scientific Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.2.5 Thermo Fisher Scientific Recent Development
11.3 F. Hoffmann-La Roche
  11.3.1 F. Hoffmann-La Roche Company Detail
  11.3.2 F. Hoffmann-La Roche Business Overview
  11.3.3 F. Hoffmann-La Roche Point of Care Infectious Disease Testing Introduction
  11.3.4 F. Hoffmann-La Roche Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Siemens Healthineers
  11.4.1 Siemens Healthineers Company Detail
  11.4.2 Siemens Healthineers Business Overview
  11.4.3 Siemens Healthineers Point of Care Infectious Disease Testing Introduction
  11.4.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.4.5 Siemens Healthineers Recent Development
11.5 BD
  11.5.1 BD Company Detail
  11.5.2 BD Business Overview
  11.5.3 BD Point of Care Infectious Disease Testing Introduction
  11.5.4 BD Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.5.5 BD Recent Development
11.6 Chembio Diagnostics
  11.6.1 Chembio Diagnostics Company Detail
  11.6.2 Chembio Diagnostics Business Overview
  11.6.3 Chembio Diagnostics Point of Care Infectious Disease Testing Introduction
  11.6.4 Chembio Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.6.5 Chembio Diagnostics Recent Development
11.7 Trinity Biotech
  11.7.1 Trinity Biotech Company Detail
  11.7.2 Trinity Biotech Business Overview
  11.7.3 Trinity Biotech Point of Care Infectious Disease Testing Introduction
  11.7.4 Trinity Biotech Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.7.5 Trinity Biotech Recent Development
11.8 Cardinal Health
  11.8.1 Cardinal Health Company Detail
  11.8.2 Cardinal Health Business Overview
  11.8.3 Cardinal Health Point of Care Infectious Disease Testing Introduction
  11.8.4 Cardinal Health Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.8.5 Cardinal Health Recent Development
11.9 Quest Diagnostics
  11.9.1 Quest Diagnostics Company Detail
  11.9.2 Quest Diagnostics Business Overview
  11.9.3 Quest Diagnostics Point of Care Infectious Disease Testing Introduction
  11.9.4 Quest Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.9.5 Quest Diagnostics Recent Development
11.10 Bio-Rad Labs
  11.10.1 Bio-Rad Labs Company Detail
  11.10.2 Bio-Rad Labs Business Overview
  11.10.3 Bio-Rad Labs Point of Care Infectious Disease Testing Introduction
  11.10.4 Bio-Rad Labs Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.10.5 Bio-Rad Labs Recent Development
11.11 bioMйrieux
  11.11.1 bioMйrieux Company Detail
  11.11.2 bioMйrieux Business Overview
  11.11.3 bioMйrieux Point of Care Infectious Disease Testing Introduction
  11.11.4 bioMйrieux Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.11.5 bioMйrieux Recent Development
11.12 Sight Diagnostics
  11.12.1 Sight Diagnostics Company Detail
  11.12.2 Sight Diagnostics Business Overview
  11.12.3 Sight Diagnostics Point of Care Infectious Disease Testing Introduction
  11.12.4 Sight Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.12.5 Sight Diagnostics Recent Development
11.13 Gene POC
  11.13.1 Gene POC Company Detail
  11.13.2 Gene POC Business Overview
  11.13.3 Gene POC Point of Care Infectious Disease Testing Introduction
  11.13.4 Gene POC Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.13.5 Gene POC Recent Development
11.14 Trivitron Healthcare
  11.14.1 Trivitron Healthcare Company Detail
  11.14.2 Trivitron Healthcare Business Overview
  11.14.3 Trivitron Healthcare Point of Care Infectious Disease Testing Introduction
  11.14.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.14.5 Trivitron Healthcare Recent Development
11.15 OJ-Bio
  11.15.1 OJ-Bio Company Detail
  11.15.2 OJ-Bio Business Overview
  11.15.3 OJ-Bio Point of Care Infectious Disease Testing Introduction
  11.15.4 OJ-Bio Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.15.5 OJ-Bio Recent Development
11.16 Ortho-Clinical Diagnostics
  11.16.1 Ortho-Clinical Diagnostics Company Detail
  11.16.2 Ortho-Clinical Diagnostics Business Overview
  11.16.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Introduction
  11.16.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023)
  11.16.5 Ortho-Clinical Diagnostics Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global Point of Care Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of HIV POC
Table 3. Key Players of HBV POC
Table 4. Key Players of Pneumonia or Streptococcus Associated Infections
Table 5. Key Players of Respiratory Syncytial Virus (RSV) POC
Table 6. Key Players of HPV POC
Table 7. Key Players of Influenza POC
Table 8. Key Players of Others
Table 9. Global Point of Care Infectious Disease Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Point of Care Infectious Disease Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Point of Care Infectious Disease Testing Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Point of Care Infectious Disease Testing Market Share by Region (2018-2023)
Table 13. Global Point of Care Infectious Disease Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Point of Care Infectious Disease Testing Market Share by Region (2024-2029)
Table 15. Point of Care Infectious Disease Testing Market Trends
Table 16. Point of Care Infectious Disease Testing Market Drivers
Table 17. Point of Care Infectious Disease Testing Market Challenges
Table 18. Point of Care Infectious Disease Testing Market Restraints
Table 19. Global Point of Care Infectious Disease Testing Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Point of Care Infectious Disease Testing Market Share by Players (2018-2023)
Table 21. Global Top Point of Care Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Infectious Disease Testing as of 2022)
Table 22. Ranking of Global Top Point of Care Infectious Disease Testing Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Point of Care Infectious Disease Testing Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Point of Care Infectious Disease Testing Product Solution and Service
Table 26. Date of Enter into Point of Care Infectious Disease Testing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Point of Care Infectious Disease Testing Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Point of Care Infectious Disease Testing Revenue Market Share by Type (2018-2023)
Table 30. Global Point of Care Infectious Disease Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Point of Care Infectious Disease Testing Revenue Market Share by Type (2024-2029)
Table 32. Global Point of Care Infectious Disease Testing Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Point of Care Infectious Disease Testing Revenue Market Share by Application (2018-2023)
Table 34. Global Point of Care Infectious Disease Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Point of Care Infectious Disease Testing Revenue Market Share by Application (2024-2029)
Table 36. North America Point of Care Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Point of Care Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Point of Care Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Point of Care Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. Europe Point of Care Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Point of Care Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
Table 42. Asia-Pacific Point of Care Infectious Disease Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 43. Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Point of Care Infectious Disease Testing Market Size by Region (2024-2029) & (US$ Million)
Table 45. Latin America Point of Care Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Latin America Point of Care Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Point of Care Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
Table 48. Middle East & Africa Point of Care Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Point of Care Infectious Disease Testing Market Size by Country (2024-2029) & (US$ Million)
Table 51. Alere Company Detail
Table 52. Alere Business Overview
Table 53. Alere Point of Care Infectious Disease Testing Product
Table 54. Alere Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 55. Alere Recent Development
Table 56. Thermo Fisher Scientific Company Detail
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Point of Care Infectious Disease Testing Product
Table 59. Thermo Fisher Scientific Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. F. Hoffmann-La Roche Company Detail
Table 62. F. Hoffmann-La Roche Business Overview
Table 63. F. Hoffmann-La Roche Point of Care Infectious Disease Testing Product
Table 64. F. Hoffmann-La Roche Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 65. F. Hoffmann-La Roche Recent Development
Table 66. Siemens Healthineers Company Detail
Table 67. Siemens Healthineers Business Overview
Table 68. Siemens Healthineers Point of Care Infectious Disease Testing Product
Table 69. Siemens Healthineers Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 70. Siemens Healthineers Recent Development
Table 71. BD Company Detail
Table 72. BD Business Overview
Table 73. BD Point of Care Infectious Disease Testing Product
Table 74. BD Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 75. BD Recent Development
Table 76. Chembio Diagnostics Company Detail
Table 77. Chembio Diagnostics Business Overview
Table 78. Chembio Diagnostics Point of Care Infectious Disease Testing Product
Table 79. Chembio Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 80. Chembio Diagnostics Recent Development
Table 81. Trinity Biotech Company Detail
Table 82. Trinity Biotech Business Overview
Table 83. Trinity Biotech Point of Care Infectious Disease Testing Product
Table 84. Trinity Biotech Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 85. Trinity Biotech Recent Development
Table 86. Cardinal Health Company Detail
Table 87. Cardinal Health Business Overview
Table 88. Cardinal Health Point of Care Infectious Disease Testing Product
Table 89. Cardinal Health Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 90. Cardinal Health Recent Development
Table 91. Quest Diagnostics Company Detail
Table 92. Quest Diagnostics Business Overview
Table 93. Quest Diagnostics Point of Care Infectious Disease Testing Product
Table 94. Quest Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 95. Quest Diagnostics Recent Development
Table 96. Bio-Rad Labs Company Detail
Table 97. Bio-Rad Labs Business Overview
Table 98. Bio-Rad Labs Point of Care Infectious Disease Testing Product
Table 99. Bio-Rad Labs Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 100. Bio-Rad Labs Recent Development
Table 101. bioMйrieux Company Detail
Table 102. bioMйrieux Business Overview
Table 103. bioMйrieux Point of Care Infectious Disease Testing Product
Table 104. bioMйrieux Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 105. bioMйrieux Recent Development
Table 106. Sight Diagnostics Company Detail
Table 107. Sight Diagnostics Business Overview
Table 108. Sight Diagnostics Point of Care Infectious Disease Testing Product
Table 109. Sight Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 110. Sight Diagnostics Recent Development
Table 111. Gene POC Company Detail
Table 112. Gene POC Business Overview
Table 113. Gene POC Point of Care Infectious Disease Testing Product
Table 114. Gene POC Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 115. Gene POC Recent Development
Table 116. Trivitron Healthcare Company Detail
Table 117. Trivitron Healthcare Business Overview
Table 118. Trivitron Healthcare Point of Care Infectious Disease Testing Product
Table 119. Trivitron Healthcare Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 120. Trivitron Healthcare Recent Development
Table 121. OJ-Bio Company Detail
Table 122. OJ-Bio Business Overview
Table 123. OJ-Bio Point of Care Infectious Disease Testing Product
Table 124. OJ-Bio Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 125. OJ-Bio Recent Development
Table 126. Ortho-Clinical Diagnostics Company Detail
Table 127. Ortho-Clinical Diagnostics Business Overview
Table 128. Ortho-Clinical Diagnostics Point of Care Infectious Disease Testing Product
Table 129. Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Testing Business (2018-2023) & (US$ Million)
Table 130. Ortho-Clinical Diagnostics Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Point of Care Infectious Disease Testing Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Point of Care Infectious Disease Testing Market Share by Type: 2022 VS 2029
Figure 3. HIV POC Features
Figure 4. HBV POC Features
Figure 5. Pneumonia or Streptococcus Associated Infections Features
Figure 6. Respiratory Syncytial Virus (RSV) POC Features
Figure 7. HPV POC Features
Figure 8. Influenza POC Features
Figure 9. Others Features
Figure 10. Global Point of Care Infectious Disease Testing Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Point of Care Infectious Disease Testing Market Share by Application: 2022 VS 2029
Figure 12. Hospitals Case Studies
Figure 13. Clinics Case Studies
Figure 14. Home Case Studies
Figure 15. Others Case Studies
Figure 16. Point of Care Infectious Disease Testing Report Years Considered
Figure 17. Global Point of Care Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Point of Care Infectious Disease Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Point of Care Infectious Disease Testing Market Share by Region: 2022 VS 2029
Figure 20. Global Point of Care Infectious Disease Testing Market Share by Players in 2022
Figure 21. Global Top Point of Care Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Infectious Disease Testing as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Point of Care Infectious Disease Testing Revenue in 2022
Figure 23. North America Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Point of Care Infectious Disease Testing Market Share by Country (2018-2029)
Figure 25. United States Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Point of Care Infectious Disease Testing Market Share by Country (2018-2029)
Figure 29. Germany Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Point of Care Infectious Disease Testing Market Share by Region (2018-2029)
Figure 37. China Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Point of Care Infectious Disease Testing Market Share by Country (2018-2029)
Figure 45. Mexico Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Point of Care Infectious Disease Testing Market Share by Country (2018-2029)
Figure 49. Turkey Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Point of Care Infectious Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Alere Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 54. Siemens Healthineers Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 55. BD Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 56. Chembio Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 57. Trinity Biotech Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 58. Cardinal Health Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 59. Quest Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 60. Bio-Rad Labs Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 61. bioMйrieux Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 62. Sight Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 63. Gene POC Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 64. Trivitron Healthcare Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 65. OJ-Bio Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 66. Ortho-Clinical Diagnostics Revenue Growth Rate in Point of Care Infectious Disease Testing Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed


More Publications